Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Narayan

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cancers|November 9, 2024
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Edouard H Nicaise, Taylor Goodstein, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
Chemistry & Biology|July 31, 2012
ALDH2 mediates 5-nitrofuran activity in multiple speciesLinna Zhou, Hironori Ishizaki, Michaela Spitzer, et al.
Cell Chemical Biology|November 20, 2020
ALDH2 Mediates 5-Nitrofuran Activity in Multiple SpeciesLinna Zhou, Hironori Ishizaki, Michaela Spitzer, et al.
Urology Practice|November 21, 2025
Why Radical vs Partial Nephrectomy Matters in Patients With Preexisting Renal Dysfunction: Exploring Chronic Kidney Disease Progression by StageReza Lahiji, Ernest A Morton, Lorenzo Storino Ramacciotti, et al.
Clinical Genitourinary Cancer|December 22, 2024
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two DecadesBenjamin D Hopkins, David C Qian, Karen M Xu, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancers|November 9, 2024
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Edouard H Nicaise, Taylor Goodstein, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
Chemistry & Biology|July 31, 2012
ALDH2 mediates 5-nitrofuran activity in multiple speciesLinna Zhou, Hironori Ishizaki, Michaela Spitzer, et al.
Cell Chemical Biology|November 20, 2020
ALDH2 Mediates 5-Nitrofuran Activity in Multiple SpeciesLinna Zhou, Hironori Ishizaki, Michaela Spitzer, et al.
Urology Practice|November 21, 2025
Why Radical vs Partial Nephrectomy Matters in Patients With Preexisting Renal Dysfunction: Exploring Chronic Kidney Disease Progression by StageReza Lahiji, Ernest A Morton, Lorenzo Storino Ramacciotti, et al.
Clinical Genitourinary Cancer|December 22, 2024
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two DecadesBenjamin D Hopkins, David C Qian, Karen M Xu, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
Pageof 6